EcoR1 Capital, LLC

Insider Reports History

Entity
Company
Location
357 Tehama Street #3, San Francisco, California
Signature
Oleg Nodelman, Manager of EcoR1 Capital, LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by EcoR1 Capital, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mirati Therapeutics, Inc. 10%+ Owner Common Stock 7.4M $437M $59.02 Dec 18, 2023 Indirect
PROTHENA CORP PUBLIC LTD CO 10%+ Owner Ordinary Shares 11.6M $336M $29.02 May 5, 2022 Indirect
ANAPTYSBIO, INC 10%+ Owner Common Stock 7.79M $285M $36.50 Aug 14, 2024 Indirect
Zymeworks Inc. 10%+ Owner Common Stock 13.4M $151M $11.22 Jun 16, 2023 Indirect
Tango Therapeutics, Inc. 10%+ Owner Common Stock 13.3M $112M $8.39 Oct 13, 2023 Indirect
Mersana Therapeutics, Inc. 10%+ Owner Common Stock 19.4M $52.5M $2.71 Jul 27, 2023 Indirect
Zymeworks Inc. 10%+ Owner Pre-Funded Warrants 5.09M $50M $9.83 Dec 26, 2023 Indirect
Graphite Bio, Inc. 10%+ Owner Common Stock 8.54M $34.8M $4.08 Jan 6, 2023 Indirect
Voyager Therapeutics, Inc. 10%+ Owner Common Stock 3.85M $27.5M $7.15 Jan 11, 2023 Indirect
TScan Therapeutics, Inc. 10%+ Owner Voting Common Stock 5M $24.8M $4.97 May 26, 2023 Indirect
Corvus Pharmaceuticals, Inc. 10%+ Owner Common Stock 81.1K $64.1K $0.79 Oct 1, 2021 Indirect
Adaptimmune Therapeutics PLC 10%+ Owner Ordinary Shares 164M Mar 8, 2024 Indirect
Odonate Therapeutics, Inc. 10%+ Owner Common Stock 0 $1.57 Dec 10, 2021 Indirect

Insider Reports Filed by EcoR1 Capital, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANAB ANAPTYSBIO, INC Aug 14, 2024 1 $10M 4 Aug 16, 2024 10%+ Owner
ADAP Adaptimmune Therapeutics PLC Mar 8, 2024 0 $0 3 Mar 26, 2024 10%+ Owner
ZYME Zymeworks Inc. Dec 26, 2023 1 $50M 4 Dec 28, 2023 10%+ Owner
MRTX Mirati Therapeutics, Inc. Dec 18, 2023 0 $0 3 Dec 27, 2023 10%+ Owner
TNGX Tango Therapeutics, Inc. Oct 13, 2023 0 $0 3 Oct 16, 2023 10%+ Owner
MRSN Mersana Therapeutics, Inc. Jul 27, 2023 0 $0 3 Jul 31, 2023 10%+ Owner
ZYME Zymeworks Inc. Jun 16, 2023 1 $27.2M 4 Jun 21, 2023 10%+ Owner
TCRX TScan Therapeutics, Inc. May 26, 2023 0 $0 3 Jun 5, 2023 10%+ Owner
ZYME Zymeworks Inc. Mar 28, 2023 1 $1.6M 4 Mar 30, 2023 10%+ Owner
ZYME Zymeworks Inc. Jan 19, 2023 2 $2.98M 4 Jan 23, 2023 10%+ Owner
ZYME Zymeworks Inc. Jan 13, 2023 3 $9.7M 4 Jan 18, 2023 10%+ Owner
ZYME Zymeworks Inc. Jan 10, 2023 2 $7.87M 4 Jan 12, 2023 10%+ Owner
VYGR Voyager Therapeutics, Inc. Jan 9, 2023 3 -$7.14M 4 Jan 11, 2023 10%+ Owner
GRPH Graphite Bio, Inc. Jan 6, 2023 0 $0 3 Jan 6, 2023 10%+ Owner
ZYME Zymeworks Inc. Oct 31, 2022 0 $0 3 Nov 1, 2022 10%+ Owner
VYGR Voyager Therapeutics, Inc. Jun 21, 2022 2 $2.66M 4 Jun 23, 2022 10%+ Owner
ANAB ANAPTYSBIO, INC May 5, 2022 2 $0 4 May 9, 2022 10%+ Owner
PRTA PROTHENA CORP PUBLIC LTD CO May 5, 2022 2 $0 4 May 9, 2022 10%+ Owner
VYGR Voyager Therapeutics, Inc. Apr 21, 2022 0 $0 3 Apr 25, 2022 10%+ Owner
PRTA PROTHENA CORP PUBLIC LTD CO Jan 12, 2022 1 $11.3M 4 Jan 12, 2022 10%+ Owner
ODT Odonate Therapeutics, Inc. Dec 1, 2021 5 -$9.43M 4 Dec 10, 2021 10%+ Owner
ODT Odonate Therapeutics, Inc. Nov 17, 2021 0 $0 3 Nov 18, 2021 10%+ Owner
CRVS Corvus Pharmaceuticals, Inc. Sep 30, 2021 2 -$25.1M 4 Oct 1, 2021 10%+ Owner
CRVS Corvus Pharmaceuticals, Inc. Sep 22, 2021 0 $0 3 Sep 22, 2021 10%+ Owner
PRTA PROTHENA CORP PUBLIC LTD CO Jun 18, 2021 2 $7.5M 4 Jun 22, 2021 10%+ Owner